FDA Official Apologizes After Misrepresenting Data Regarding Blood Plasma As COVID-19 Treatment

U.S. Commissioner of Food and Drugs Stephen Hahn participates in a roundtable discussion on donating plasma at the American Red Cross National Headquarters in Washington on July 30, 2020. Jim Watson/AFP via Getty Images

An FDA health official issued an apology on Monday, after admitting he had overstated the benefits of blood plasma for COVID-19 treatment.

Dr. Stephen Hahn, the commissioner for the U.S. Food and Drug Administration, stated that he had misrepresented an important data set regarding the effectiveness of blood plasma for treating COVID-19 in a news release issued on Sunday.